Accelerating trials, inspiring the future:
The trusted partner
for 95% of all
FDA-approved therapeutic agents last year.
We connect clinical research sponsors, CROs, sites, and participants to deliver efficient, safe, and impactful clinical research.
What’s slowing down your clinical trials?
Long study start-up and trial duration?
- Our average full-board IRB determinations arrive 20% ahead of targeted TAT, accelerating site activation and study start up.
- Complete study start-up 37% faster, and connect with the right sites with our leading database of historical performance for sites and investigators.
Explore our solutions for:
Increased competition for sites and participants?
- We enable smarter, faster and more cost-effective research sites, increasing capacity and performance.
- 80% of all clinical trials fail to meet patient enrollment targets. Improve your participant engagement and study enrollment with our solutions.
Explore our solutions for:
Increased protocol complexity?
- Reduce error rates for endpoints by up to 65% with industry-leading protocols and platforms shaped by scientific experts.
- Share knowledge with 220+ peer organizations in a collaborative, pre-competitive consortium, while driving efficiencies with 500+ best practice tools.
Explore our approach to
WCG by the numbers
Our connectivity, solutions, data intelligence, and expertise support your success.
years experience in independent review solutions
Explore our history
biopharma and CRO clients (including 50 of 50 top pharma and 8 of 8 top CROs)
participants in WCG-supported studies
See how we support research participants
Understanding the FDA’s new proposed regulations on human subject research and their impact on your clinical trial plansVideos
Diversity Action Plans Will Soon Be Mandatory for Clinical TrialsBlog Posts
WCG Releases 2023 Report on Top Issues Impacting Clinical Research SitesNews
In Focus Topics
Clinical Trial Operations
Clinical Trial Safety
Cell & Gene Therapy
A trusted partner for more than 55 years
The clinical trial industry faces strong headwinds – new trial designs, too many technology platforms, greater complexity – all of which requires a new, more modern approach. WCGs global reach and purpose-built solutions are designed to connect sponsors, CROs, sites, and participants across the industry to navigate the future of clinical research and help bring life-saving therapies to patients faster.
Join our thought leaders for deeper dives into the clinical trial industry.
Mid-sized BioPharma Closes Enrollment 3 Months Ahead of Schedule
- Enrollment closed nearly 3 months ahead of schedule, which had only seemed impossible.
- The client was able to bolster enrollment because the media outreach came in under budget and funds were reallocated to site support.
- Additionally, 118 of the 272 documents reviewed were given suggestions for improvement in accordance with ICH (E6) R2 and industry-leading practices.